Physician profile
Gregory Gullo
NPI 1124075791
$4,493.99
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,683 · 2020: $2,044 · 2021: $502 · 2022: $250 · 2023: $14.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,207.01 | 2019-2022 | |
| Vgi Medical, LLC | $444.80 | 2020 | |
| Pfizer INC. | $292.70 | 2019-2020 | |
| Daiichi Sankyo INC. | $290.23 | 2019 | |
| Nevro Corp. | $255.29 | 2019-2020 | |
| Lilly USA, LLC | $254.13 | 2019-2022 | |
| Allergan, INC. | $221.23 | 2020-2021 | |
| Biodelivery Sciences International, INC. | $179.62 | 2019-2021 | |
| Grt US Holding, INC. | $135.37 | 2021 | |
| Medtronic USA, INC. | $130.46 | 2019 | |
| Amgen INC. | $121.03 | 2019-2021 | |
| Stimwave Technologies Incorporated | $109.05 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $96.89 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $92.69 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $89.05 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $77.43 | 2021 | |
| Zyla Life Sciences, INC. | $69.05 | 2019-2020 | |
| Abbvie INC. | $68.16 | 2022-2023 | |
| Arbor Pharmaceuticals, INC. | $53.49 | 2019-2021 | |
| Mdd US Operations, LLC | $53.12 | 2020 | |
| Pacira Therapeutics, INC. | $46.78 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $34.10 | 2022 | |
| Tersera Therapeutics LLC | $33.87 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.26 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $27.17 | 2020 | |
| Si-Bone, INC. | $26.84 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.58 | 2020 | |
| Assertio Therapeutics, INC. | $18.57 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Gullo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.